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Graphical abstract
New series of monoamidoxime derivatives displaying versatile antiparasitic activity. 
Introduction
Human visceral leishmaniasis (VL) is a major public health problem [1] mainly caused by two species of a parasite from the Trypanosomatidae family: Leishmania donovani and Infantum, flagellate protozoans. A total of 98 countries and 3 territories on 5 continents reported endemic leishmaniasis transmission, with 200 to 400,000 new cases of visceral leishmaniasis declared yearly. [2] In line with our general interest in the preparation of original molecules with pharmacological properties, [7] [8] [9] [10] [11] our team developed the radical synthesis of mono-and diarylamidoxime derivatives mediated by manganese(III) acetate.
Manganese(III) acetate has been extensively explored during the past decades (especially oxidative free-radical cyclization), and it remains a useful tool for carbon-carbon bond formation. [12] [13] [14] Recently, it enabled 40 mono-and diamidoximes to be synthesized, showing antileishmaniasis potential with valuable antiparasitic activities. [15] [16] Findings highlighted the antileishmanial potential of monoamidoxime derivatives, which was increased by fluorine atom or trifluoromethyl groups on the β-ketosulfone moiety. This yielded 4-(5-benzyl-3-(4-fluorophenylsulfonyl)-5-methyl-4,5-dihydrofuran-2-yl)-N'-hydroxy-benzimidamide ( Figure 1 ): this molecule presents good in vitro antileishmanial activity on L. donovani promastigotes, with a better selectivity index (SI = 6.37) than conventional antileishmanial drugs (pentamidine, amphotericin B). [16] In continuation of our research program centered on the design and synthesis of original molecules with pharmacological properties, further pharmacomodulations of R 1 , R 2 and R 3 groups ( Figure 2 ) were carried out in order to obtain new monoamidoxime derivatives with better antileishmanial activity. Monoamidoximes were obtained using a free radical mechanism mediated by manganese(III) acetate. Suzuki-Miyaura cross-coupling reactions were also carried out to further explore the pharmacological potential.
In addition, the antiparasitic activities of the amidoxime derivatives obtained were assessed both on L. donovani promastigotes and P. falciparum. To date, the molecules synthesized by our research team have exhibited good activity against L. donovani promastigotes, and we wanted to determine the selectivity of this action among protozoa. Thus, assessments of both antiplasmodial and antileishmanial properties were performed for the new series of amidoximes synthesized, so as to better elucidate their mechanisms of action.
Results and discussion
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Chemistry
Synthesis of monoamidoxime derivatives required several steps as reported in Scheme 1. The reaction can be undertaken under classical heating, however, it has been shown that microwave irradiations dramatically improve yields, decrease reaction time and side reactions occurring. [20] a Yield of isolated product based on the corresponding β-ketosulfone.
Scheme 1. Monoamidoxime derivatives synthetic pathway.
Reagents and conditions: (i)
Synthesis of 2,3-dihydrofurane derivatives by oxidative free-radical cyclization mediated by manganese(III) acetate led to variable outcomes with regard to yields, according to the alkene used: alkenes with methoxy group (9-10) hardly react under classic conditions. [24] [25] We hypothesized that methoxy-group interferes with manganese acetate, therefore more equiv. of manganese (III) M A N U S C R I P T
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5 acetate and copper(II) acetate were used to achieve the reaction in better yield (compound 20 was not obtained under classical conditions, and obtained with 27% yields when number of equivalent of Mn(OAc) 3 and Cu(OAc) 2 were doubled). Compounds 22 and 23 were also obtained with low yields, as alkenes exhibiting electron withdrawal substituents are known for their lack of reactivity. [20] In order to establish structure-activity relationships, pharmacomodulations were done, using palladium-catalyzed coupling reactions of a molecule bearing a bromine atom were investigated according to previously described studies. [26] [27] [28] [29] Reaction parameters were assessed using 4-[5-(4-bromophenyl)-3-(4-fluorophenylsulfonyl)-5-methyl-4,5-dihydrofuran-2-yl]benzonitrile (22) as the substrate of p-tolylbenzeneboronic acid (Table 2) , in order to optimize yields. Good yields were achieved with polar solvents only (DMF, toluene:ethanol); likewise, microwave irradiation leads to better yields and dramatically reduces reaction time. Outcomes revealed reaction parameter of assay 6 lead to quantitative yield, thus these reaction conditions were applied for further cross-coupling reactions. A series of 8 varied functionalized molecules (24-31) was obtained in moderate to quantitative yields (Table 3) . Excellent yields were obtained with boronic acids exhibiting electron-withdrawal substituents (compounds 24 and 31). It is worth noting that the substituent position influences the reactivity of boronic acids: p-cyanophenylboronic acid showed a better reactivity (compound 25) than ocyanophenylboronic acid (compound 29) and m-cyanophenylboronic acid (compound 30). With regard to heteroarylboronic acids, furan-2-ylboronic acid well reacted (83%) whereas pyridin-4-ylboronic acid reactivity was moderate.
The reaction of cyano derivatives synthesized from both cyclization mediated by manganese(III) acetate and Suzuki-Miyaura cross-coupling reactions (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) , with hydroxylamine hydrochloride and potassium tert-butoxide in DMSO [30] led to conversion of the cyano group into amidoximes 32-51 in moderate to excellent yields (28-100%) as reported in Table 4 . almost halves the reaction yield. The conversion of two cyano groups occurs for compounds 45 and 50 but not for compound 49, due to sterically hindered derivative. Inductive effect of nitro group probably enhances a side reaction leading to nitrobenzamide derivatives [30] , hence the lower yield for compound 47.
Biology
All amidoxime derivatives synthesized (32-51) underwent in vitro biological assessment: the first step toward synthesizing compounds of therapeutic interest was determining whether these compounds presented a toxic profile or if they could offer in vitro selective antiparasitic properties. Consequently, a cytotoxicity evaluation was realized via the MTT method [31] to determine cytotoxic concentrations of 50% (CC 50 ) and using doxorubicin as a cytotoxic reference-compound. These assays were performed with respect to two complementary cell lines: mouse J774A.1 macrophages (J774A.1 CC 50 ) and human HepG2 (HepG2 CC 50 ). J774A.1 macrophages are commonly used as in vitro host cell models for the screening of antileishmanial drugs allowing intracellular stage amastigote L. donovani to develop. [16] HepG2 is a commonly used human-derived hepatocarcinoma cell line that has shown characteristics similar to those of primary hepatocytes. These cells express many of the hepatocytespecific metabolic enzymes, thus enabling the cytotoxicity of tested product metabolites to be evaluated. Then, molecules were tested for their activity (Ld promastigotes IC 50 ) against promastigotes (strain MHOM/IN/00/DEVI). Two reference drug compounds, amphotericine B and pentamidine, were tested under identical conditions. All tested compounds were also assessed for their in vitro antiplasmodial activity against a K1 multi-resistant strain of Plasmodium falciparum, using the SYBR Green I fluorescence-based method. [32, 33] In order to identify compounds with significant potential, two reference drug compounds, chloroquine and doxycycline, were also tested under the same conditions. Their inhibitory concentrations 50% (PfK1 IC 50 ) were then calculated, as well as their selectivity indexes (SI). For each assay, three independent experiments in duplicate were performed. Outcomes are summarized in Table 5 . a The values are means ± SD of three independent experiments.
b Selectivity Index was calculated according to the formula : SI = (J774A.1 CC50) / (L. donovani IC50).
c Selectivity Index was calculated according to the formula : SI = (HepG2 CC50) / (K1 IC50).
d Determination of the IC50 or CC50 value was limited by lack of solubility in the culture medium.
e Doxorubicin was used as a cytotoxic drug compound of reference.
f Amphotericin B and pentamidine were used as antileishmanial drug compounds of reference.
g Chloroquine and doxycycline were used as antiplasmodial drug compounds of reference.
The evaluation revealed that almost all the compounds are twice as toxic in vitro toward J774A.1 macrophages as HepG2 cells. This result suggests firstly that there is product metabolization by hepatocyte-specific metabolic enzymes in the HepG2 cell line, and secondly that these metabolites are less toxic in vitro than tested compounds. Several amidoximes possessing a methyl in R 2 , a benzyl in R 3 and a variously monosubstituted phenyl group in R 1 (32) (33) (34) (35) 13 C chemical shifts were referenced to the solvent peaks: CDCl 3 (76.9 ppm) or DMSO-d6 (39.6 ppm). Coupling constants (J values) are given in hertz. NMR multiplicities are abbreviated as follows: s (singlet), bs (broad singlet), d (doublet), t (triplet), q (quartet) and m (a more complex multiplet or overlapping multiplets). Microwave-assisted reactions were performed in a multimode microwave oven (ETHOS Synth Lab Station, Ethos start, Milestone Inc., Rockford, IL, USA) or in a monomode microwave oven for the Suzuki-Miyaura crosscoupling reactions (Biotage Initiator Microwave oven using 10-20 mL sealed vials; temperatures were measured with an IR-sensor and reaction times given as hold times). Elemental analysis and mass spectra, run on an API-QqToF mass spectrometer, were carried out at the Spectropole de la Faculté M A N U S C R I P T
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des Sciences site Saint-Jérôme. IR analysis were implemented spectra were carried out at the Spectropole de la Faculté des Sciences site Saint-Jérôme, using a thermo-Nicolet IR 200 spectrometer (4000-400 cm -1 ) coupled with Attenuated Total Reflectance technique (Spectra-Tech Foundation Thunderdome). All commercial reagents were used without purification.
General preparation of β-Ketosulfones
Sodium sulfite (1.26 g, 10 mmol) and sodium bicarbonate (0.84 g, 10 mmol) were added to a solution of sulfonyl chloride (6.00 mmol) in water (15 mL). The reaction mixture was heated under reflux in a microwave oven under irradiation (500 W, 100 °C) for 15 min. Then, an ethanolic solution of the corresponding acetophenone (6 mmol) was added. Heating of the reaction mixture was continued for 45 min under the same conditions. After cooling, the reaction mixture was filtered and the precipitate thus formed was crystallized from isopropanol. 
4-[2-(2-fluorophenylsulfonyl)acetyl]benzonitrile (1).
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General preparation of alkenes using Wittig reaction
Methyltriphenylphosphonium bromide (4.38 g, 11.1 mmol, 1.2 equiv.) and potassium tert-butoxide (1.24 g, 11.1 mmol, 1.2 equiv.) were added in anhydrous diethylether (50 mL) in order to form phosphorus ylide. The bright yellow reaction mixture was heated for 60 min under inert atmosphere. Ketone (9.25 mmol, 1 equiv.) was added progressively at room temperature, as this results in an exothermic reaction. The reaction mixture was heated for 12 h under the same conditions. Then, the reaction mixture was poured into 100 mL of cold water and extracted with diethyl ether (3 × 50 mL).
The organics extracts were collected and washed with saturated aqueous NaHCO 3 (3 × 50 mL) and dried (MgSO 4 ). Solvent was evaporated under reduced pressure and crude product was purified by column chromatography with an appropriate solvent.
1,1-diphenylethene (8).
[34] Colorless oil, yield 81%. Compound purified by silica gel column chromatography eluting with petroleum ether and dichloromethane (9:1). 1 ) and alkene (6.54 mmol, 2 equiv.) in acetic acid was added. The reaction mixture was heated for 45 min under the same conditions, poured into 200 mL of cold water and extracted with dichloromethane (3 × 40 mL). The organic extracts were collected and washed with saturated aqueous NaHCO 3 (3 × 40 mL) and dried (MgSO 4 ). Solvent was evaporated under reduced pressure and crude product was purified by column chromatography with an appropriate solvent, and the product obtained was recrystallized from the appropriate solvent. under microwave irradiation. Then the reaction mixture was evaporated and filtrated on Celite 545 using dichloromethane as solvent. The filtrate was poured into 100 mL of water and extracted with dichloromethane (3 × 40 mL). The organics extracts were collected and washed with saturated aqueous NaHCO 3 (3 × 40 mL) and dried (MgSO 4 ). Solvent was evaporated under reduced pressure and crude product was purified by column chromatography with an appropriate solvent. 
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General procedure for Mn(OAc) 3 -mediated reaction of β-Ketosulfones with alkenes
4-[5-benzyl-3-(2-fluorophenylsulfonyl)-5-methyl-4,5-dihydrofuran-2-yl]benzonitrile (12
4-[5-benzyl-3-(3-fluorophenylsulfonyl)-5-methyl-4,5-dihydrofuran-2-yl]benzonitrile (13
General procedure for Suzuki-Miyaura cross-coupling
4-[3-(4-fluorophenylsulfonyl)-5-methyl-5-(4'-methylbiphenyl-4-yl)-4,5-dihydrofuran-2-yl]benzonitrile (24
4'-[5-(4-cyanophenyl)-4-(4-fluorophenylsulfonyl)-2-methyl-2,3-dihydrofuran-2-yl]biphenyl-4-carbonitrile (25
4-[3-(4-fluorophenylsulfonyl)-5-(4-(furan-2-yl)phenyl)-5-methyl-4,5-dihydrofuran-2-yl]benzonitrile (26
4-[3-(4-fluorophenylsulfonyl)-5-methyl-5-(3'-nitrobiphenyl-4-yl)-4,5-dihydrofuran-2-yl]benzonitrile (27
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4-[3-(4-fluorophenylsulfonyl)-5-methyl-5-(4-(pyridin-4-yl)phenyl)-4,5-dihydrofuran-2-yl]benzonitrile (28
4'-[5-(4-cyanophenyl)-4-(4-fluorophenylsulfonyl)-2-methyl-2,3-dihydrofuran-2-yl]biphenyl-3-carbonitrile (30
General procedure for amidoximes synthesis from nitriles
A suspension of hydroxylamine hydrochloride (1.7 mmol, 0.12 g, 10 equiv.) in 8 mL of DMSO was stirred under inert atmosphere and cooled down to 5 o C. Potassium terbutoxide (1.7 mmol, 0.19 g, 10 equiv.) was added progressively and the reaction mixture was stirred for 30 min. Then the M A N U S C R I P T
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corresponding nitrile was added (0.17 mmol, 1 equiv.) and the reaction mixture was stirred for 12-72 h. The mixture obtained was poured into cold water and the precipitate thus formed was filtrated and crystallized from the appropriate solvent. 
4-[5-benzyl-3-(2-fluorophenylsulfonyl)-5-methyl-4,5-dihydrofuran-2-yl]-N'-hydroxybenzimidamide (32
4-{5-benzyl-5-methyl-3-[3-(trifluoromethyl)phenylsulfonyl]-4,5-dihydrofuran-2-yl}-N'-hydroxybenzimidamide (35
Biology
General
Reagents for cell culture media and compound screening included Schneider's medium (Invitrogen), RPMI 1640 (PAA), foetal calf serum (FCS) (PAA), L-glutamine-penicillin-streptomycin solution (Sigma), thiazolyl blue tetrazolium bromide (MTT) and dimethyl sulfoxide (DMSO) (Sigma). Stock solutions of amidoxime derivatives and reference drugs (doxorubicin, amphotericin B, pentamidine, chloroquine and doxycycline all from Sigma) were prepared in DMSO.
In vitro cytotoxicity evaluation
The evaluation of the tested molecules cytotoxicity on the HepG2 (hepatocarcinoma cell line purchased from ATCC, ref HB-8065) and J774A.1 (mouse macrophage cell line ECACC, Salisbury UK) cell lines was performed according to the method of Mosman [31] with slight modifications.
Briefly, cells 5 x 10 3 in 100 µL of complete medium [RPMI supplemented with 10% foetal bovine serum, 1% L-glutamine (200 mM) and penicillin (100 U/mL) / streptomycin (100 µg/mL)] were inoculated into each well of 96-well plates and incubated at 37 °C in a humidified 6% CO 2 , 14% O 2 , 80% N 2 atmosphere. After 24 h incubation, 100 µL of medium with various product concentrations (final DMSO concentration less than 0.5% v/v) was added and the plates were incubated for 72 h. Appropriate controls treated with or without solvent (DMSO), and various concentrations of doxorubicin (positive control) were added to each set of experiments. Duplicate assays were performed for each sample. At the end of the treatment and incubation, the medium was aspirated from the wells and 100 µL MTT solution (0.5mg/ml in RPMI 1640) was added to each well. Cells were incubated for 6 h at 37 °C to allow MTT oxidation by mitochondrial dehydrogenase in the viable cells. After this time, the MTT solution was aspirated and DMSO (100 µL) was added to each well to dissolve the resulting blue formazan crystals. Plates were shaken vigorously (300 rpm) for a few minutes. The absorbance was measured at 570 nm with 630 nm as reference wavelength, using a microplate spectrophotometer. DMSO was used as blank and doxorubicin as positive control. Cell viability was calculated as percentage of control (cells incubated without compound). The 50% cytotoxic concentrations (J774A.1 CC 50 and HepG2 CC 50 ) were determined by non-linear regression analysis processed on dose-response curves, using 
In vitro antileishmanial activity
The effects of the tested compounds on the growth of Leishmania donovani promastigotes were assessed by MTT assay. [31] Briefly, promastigotes in log-phase in Schneider's medium supplemented with 20% fetal calf serum (FCS), 2 mM L-glutamine and antibiotics (100 U/mL penicillin and 100 µg/mL streptomycin), were incubated at an average density of 10 6 parasites/mL in sterile 96-well plates with various concentrations of compounds dissolved in DMSO (final concentration less than 0.5% v/v), in duplicate. Appropriate controls treated by DMSO, pentamidine or amphotericin B M A N U S C R I P T
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(reference drugs) were added to each set of experiments. After a 72 h incubation period at 27 °C, parasite metabolic activity was determined. Each plate-well was then microscope-examined to detect possible precipitate formation. 10 µL of MTT solution (10 mg/mL) was added to each well followed by incubation for another 4 hours. The enzyme reaction was then stopped by adding of 100 µL of 50% isopropanol -10% sodium dodecyl sulfate. [38] Plates were shaken vigorously for a few minutes and the absorbance measured in a plate reader at 570 nm. Inhibitory concentration 50% (IC 50 ) was defined as the concentration of drug required to inhibit by 50% the metabolic activity of Leishmania donovani promastigotes compared to the control. IC 50 were calculated by non-linear regression analysis processed on dose-response curves, using TableCurve 2D V5 software. IC 50 values represent the mean value calculated from three independent experiments.
In vitro antiplasmodial activity
The evaluation of antiplasmodial activity was conducted on a K1 in vitro culture-adapted Plasmodium falciparum strain (clone of W2), resistant to chloroquine, pyrimethamine and proguanil. Cultures were maintained in fresh A+ human erythrocytes at 2.5% haematocrit in complete medium (RPMI 1640 with 25 mM HEPES, 25 mM NaHCO 3 , 10% of A+ human serum) at 37 °C under reduced O 2 atmosphere (gas mixture 6% CO 2 , 14% O 2 , 80% N 2 ). Parasitaemia was maintained daily between 1% and 6%. The Plasmodium falciparum drug susceptibility test was carried out by comparing quantities of DNA in treated and control cultures of parasite in human erythrocytes according to a SYBR Green I fluorescence-based method using a 96-well fluorescence plate reader. Parasite culture was synchronized at ring stage with 5% sorbitol. Compounds were incubated in a total assay volume of 200 µL (RPMI, 2% haematocrit and 1% parasitaemia) for 72 h in a humidified atmosphere (6% CO 2 c Selectivity Index was calculated according to the formula : SI = (HepG2 CC50) / (K1 IC50).
g Chloroquine and doxycycline were used as antiplasmodial drug compounds of reference. 
Synthesis of alkenes
